Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. This voice experience is generated by AI. Learn more.
GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Bungie has revealed its plans for the next long story arc for ...
Rare-disease specialist Catalyst Pharmaceuticals is set to be acquired by healthcare group Angelini Pharma in a $4.1 billion deal. Angelini will pay $31.50 for each of Nasdaq-listed Catalyst’s ...
With the launch of The Edge of Fate expansion for Destiny 2, all players have their Power levels reset to a much lower number than usual. This change affects all players, even those who do not own the ...
With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...
Angelini Pharma has agreed to acquire all outstanding shares of Catalyst Pharmaceuticals (CPRX) for $31.50 per share in cash, for a total equity value of approximately $4.1B. The deal has been ...
State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...
SANTA CRUZ — A small group of music fans and Santa Cruz City Council candidates have created a petition in hopes of saving the Catalyst Club in downtown Santa Cruz. The building at 1011 Pacific Ave.
The Switch 2's new Accessibility menu lets you enable various features to help you use the system if you have visual, auditory, or verbal difficulties. You can tweak the size of system text, toggle a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results